Overview:

This Powerpoint by the MAPS Evidence Generation Focus Area Working Group offers a comprehensive overview of Real World Evidence (RWE) and its evolving use in the biopharmaceutical industry.

Members: Login to Access this Content Non-Members: Buy Here

Authors:

Dr. Phil Wakefield

Dr. Phil Wakefield

Global Medical Strategy & Value Lead, MEDiSTRAVA
Clément François, MSc. PhD

Clément François, MSc. PhD

Executive Vice President, Pricing and Market Access, Creativ-Ceutical | A MEDiSTRAVA Company
Agathe Leray

Agathe Leray

Vice President, Global Business Development, Creativ-Ceutical | A MEDiSTRAVA Company
Ann Hartry, PhD

Ann Hartry, PhD

VP, Deputy Head Global Value Evidence, Lundbeck

Connect with Us

602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073

© 2025 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.

Subscribe to MAPS Newsletter
MAPS Program Support Services
Policies and Positions
Creating an HEOR Function Within Medical AffairsAlphaGroup HEORMake Communications, Not War: Best Practices for Medical, Legal and Regulatory...